One of Crisper Pioneer Feng Zhang Has Launched His Own Startup

Posted on by barland7

LIFESTYLEARTSGLOBE MAGAZINETECHNOLOGYCLIMATEEDUCATIONCARSREAL ESTATEEVENTSSearch The Boston Globe

SIGN IN

SUBSCRIBE NOW$1 for 6 months

Investors bet big on Feng Zhang’s new startup, out to solve one of gene editing’s most vexing problems

Aera Therapeutics is launching with $193 million to develop a new nanoparticle technology to deliver genetic medicines to hard-to-reach parts of the body.

By Ryan Cross Globe Staff,Updated February 16, 2023, 6:30 a.m.

2

Gene editing researcher Feng Zhang founded Aera Therapeutics to develop therapies based on a new gene delivery technology invented in his lab at the Broad Institute of MIT and Harvard.
Gene editing researcher Feng Zhang founded Aera Therapeutics to develop therapies based on a new gene delivery technology invented in his lab at the Broad Institute of MIT and Harvard.AERA THERAPEUTICS

The company, Aera Therapeutics, formally launched Thursday morning with $193 million in financing from GV and other investors including ARCH Venture Partners and Lux Capital.

Zhang is one of the inventors of Crisper.